Axsome Therapeutics, Inc. (AXSM) Financial Statements

Comprehensive financial analysis for AXSM including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed AXSM financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):N/A

Forward P/E:148.20

EPS (TTM):$-5.07

Enterprise Value:$5.47B

Profitability Ratios

Profit Margin:-49.88%

Return on Equity:-280.69%

Return on Assets:-21.90%

Operating Margin:-29.87%

Financial Health

Current Ratio:1.57

Quick Ratio:1.47

Debt to Equity:297.38

Beta (5Y):0.51

Revenue and Profit Trends

Growth Metrics

Revenue Growth

72.10%

Revenue Per Share

$10.15

Performance Metrics

Profit Margin Trend

-49.88%

Return on Equity

-280.69%

Return on Assets

-21.90%

Analyst Insights

Price Targets

Average Target

$176.95

High Target

$200.00

Low Target

$144.00

Analyst Recommendations

Recommendation

Strong Buy

Analyst Coverage

19 Analysts

Upside Potential

+51.2%